Value of interim F-18-FDG PET/CT for predicting progression-free survival in stage IIIB/IV EGFR-mutant non-small-cell lung cancer patients with EGFR-TKI therapy

Shao Dan; Cheng You; Yuan Zhi-Shan; Jiang Ben-Yuan; Wang Shu-Xia

首页> 外文期刊>Lung cancer: Journal of the International Association for the Study of Lung Cancer >Value of interim F-18-FDG PET/CT for predicting progression-free survival in stage IIIB/IV EGFR-mutant non-small-cell lung cancer patients with EGFR-TKI therapy

【24h】

Value of interim F-18-FDG PET/CT for predicting progression-free survival in stage IIIB/IV EGFR-mutant non-small-cell lung cancer patients with EGFR-TKI therapy

机译：临时F-18-FDG PET / CT用于预测IIIB / IV型EGFR-突变体非小细胞肺癌患者的无进展生存率的PET / CT的价值

获取原文

获取原文并翻译 | 示例

获取外文期刊封面封底 >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

Objectives: We retrospectively investigated the prognostic value of FDG-PET performed for patients with Stage IIIB/IV EGFR-mutant non-small-cell lung cancer (NSCLC) receiving EGFR tyrosine kinase inhibitor (TKI) therapy.

机译：None

著录项

来源
《Lung cancer: Journal of the International Association for the Study of Lung Cancer》 |2020年第1期|共7页
作者
Shao Dan; Cheng You; Yuan Zhi-Shan; Jiang Ben-Yuan; Wang Shu-Xia;
展开▼
作者单位

Guangdong Acad Med Sci Guangdong Prov Peoples Hosp Dept PET Ctr Room 526 5-F Weilun Bldg 106;

Guangdong Acad Med Sci Guangdong Prov Peoples Hosp Dept PET Ctr Room 526 5-F Weilun Bldg 106;

Guangdong Univ Technol Sch Electromech Engn Guangzhou 510006 Peoples R China;

Guangdong Acad Med Sci Guangdong Prov Peoples Hosp Guangdong Lung Canc Inst Guangzhou Peoples R;

Guangdong Acad Med Sci Guangdong Prov Peoples Hosp Dept PET Ctr Room 526 5-F Weilun Bldg 106;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类肿瘤学;
关键词
FDG PET; EGFR-TKI; Lung cancer; Prognosis;

机译：FDG PET;EGFR-TKI;肺癌;预后;

相似文献

外文文献
中文文献
专利

1. A radiomics prognostic scoring system for predicting progression-free survival in patients with stage Ⅳ non-small cell lung cancer treated with platinum-based chemotherapy [J] . Lan He, Zhenhui Li, Xin Chen, 中国癌症研究（英文版） . 2021,第005期
2. Therapy for non-small-cell lung cancer patients with brain metastasis Therapy for non-small-cell lung cancer patients with brain metastasis [J] . Bing Li, Yuchen Bao Co-first author, Bin Chen, 中德临床肿瘤学杂志（英文版） . 2014,第010期
3. Effect of etoposide plus thalidomide as maintenance therapy on progression-free survival of elderly patients with advanced non-small cell lung cancer [J] . Yanan Ge, Zhendong Zheng, Zhaozhe Liu, 肿瘤学与转化医学（英文） . 2017,第003期
4. Effect of etoposide plus thalidomide as maintenance therapy on progression-free survival of elderly patients with advanced non-small cell lung cancer [J] . Yanan Ge, Zhendong Zheng, Zhaozhe Liu, 中德临床肿瘤学杂志（英文版） . 2017,第003期
5. RRM1 gene expression in peripheral blood is predictive of shorter survival in Chinese patients with advanced non-small-cell lung cancer treated by gemcitabine and platinum [J] . Lin-run WANG, Guo-bing ZHANG, Jian CHEN, 浙江大学学报：B卷英文版 . 2011,第003期
6. The potential of F-18-FDG PET/CT in predicting PDL1 expression status in pulmonary lesions of untreated stage IIIB-IV non-small-cell lung cancer [J] . Wang Lihua, Ruan Maomei, Lei Bei, Lung cancer: Journal of the International Association for the Study of Lung Cancer . 2020,第1期

机译：F-18-FDG PET / CT在未处理阶段IIIB-IV非小细胞肺癌肺病变中预测PDL1表达状态的潜力
7. A New Approach to Predict Progression-free Survival in Stage IV EGFR-mutant NSCLC Patients with EGFR-TKI Therapy [J] . Song Jiangdian, Shi Jingyun, Dong Di, Clinical cancer research: an official journal of the American Association for Cancer Research . 2018,第15期

机译：一种新方法，以预测IV阶段EGFR-突变体NSCLC患者的无进展生存
8. F-18-FDG PET-CT: predicting recurrence in patients following percutaneous cryoablation treatment for stage I primary non-small-cell lung cancer [J] . LoGiurato Brendan, Matthews Robert, Safaie Elham, Nuclear Medicine Communications . 2015,第9期

机译：F-18-FDG PET-CT：预测经皮冷冻消融治疗I期原发性非小细胞肺癌患者的复发
9. Development and validation of a radiomics nomogram for progression-free survival prediction in stage IV EGFR-mutant non-small cell lung cancer [C] . Jiangdian Song, Yali Zang, Weimin Li, Conference on Computer-Aided Diagnosis . 2017

机译：放射组学诺模图的开发和验证，用于IV期EGFR突变非小细胞肺癌的无进展生存期预测
10. Evaluation of Symptom Management in Patients with Advanced Stage (IIIB and IV) Non-Small Cell Lung Cancer [D] . Mann, LaTonya E. 2018

机译：晚期（IIIB和IV）非小细胞肺癌患者症状管理的评估
11. Association of Tumor PD-L1 Expression with the T790M Mutation and Progression-Free Survival in Patients with EGFR-Mutant Non-Small Cell Lung Cancer Receiving EGFR-TKI Therapy [O] . Minehiko Inomata, Kenji Azechi, Naoki Takata, 2020

机译：肿瘤PD-L1表达与EGFR-突变体非小细胞肺癌接受EGFR-TKI治疗的患者T790M突变和无进展存活
12. A New Approach to Predict Progression-free Survival in Stage IV EGFR-mutant NSCLC Patients with EGFR-TKI Therapy [O] . Jiangdian Song, Jingyun Shi, Di Dong, 2018

机译：一种新方法，以预测IV阶段EGFR-突变体NSCLC患者的无进展生存
13. FLT-PET/CT as a Biomarker of Therapeutic Response in Pemetrexed Therapy for Non-Small Cell Lung Cancer. [R] . Katz, S. I. 2016

机译：FLT-pET / CT作为培美曲塞治疗非小细胞肺癌治疗反应的生物标志物。

Value of interim F-18-FDG PET/CT for predicting progression-free survival in stage IIIB/IV EGFR-mutant non-small-cell lung cancer patients with EGFR-TKI therapy

摘要

著录项

相似文献

相关主题

期刊订阅